Medicine and Dentistry
Prostate Cancer
100%
Biopsy
64%
Neoplasm
63%
Testis Cancer
42%
Prostatectomy
40%
Diagnosis
39%
Seminoma
36%
Cohort Analysis
29%
Penile Cancer
28%
Germinoma
23%
Clinical Stage
23%
Prostate Specific Antigen
22%
Transrectal Ultrasonography
22%
Malignant Neoplasm
22%
Carcinoma in Situ
21%
Biochemical Recurrence
19%
Disease
19%
Prognostic Factor
17%
Protein Expression
17%
Testes
15%
Gleason Score
14%
Recurrent Disease
14%
Lymph Node
13%
Proportional Hazards Model
12%
Surgical Margin
12%
Cancer Mortality
12%
Transcription Factor ERG
11%
Cellular Infiltration
11%
Meta-Analysis
11%
Randomized Controlled Trial
11%
Natural Killer Cell
11%
Bladder Biopsy
11%
Exercise
11%
Wart Virus
11%
Prostate Cancer Diagnosis
11%
Outpatient
11%
Positron Emission Tomography-Computed Tomography
11%
Cystoscopy
11%
Cumulative Incidence
11%
Immunohistochemistry
10%
Squamous Cell Carcinoma
10%
Cancer Registry
9%
Castration Resistant Prostate Cancer
9%
Germ Cell Cancer
9%
Bladder
9%
Sentinel Node
8%
Symptom
8%
Diagnostic Accuracy
8%
Fluorodeoxyglucose
8%
Tumor Progression
8%
Keyphrases
Radical Prostatectomy
49%
Prostate Cancer
48%
Testicular Cancer
36%
Tumor
31%
Denmark
30%
Penile Cancer
28%
Carcinoma in Situ
26%
Clinical Stage I
22%
Clinically Significant Prostate Cancer
22%
Seminoma
21%
Risk Factors
20%
Prostatectomy Specimen
19%
Localized Prostate Cancer
19%
Prostate Cancer Risk
19%
Testicular Germ Cell Tumor
19%
National Cohort Study
18%
Prostate-specific Antigen
18%
Germ Cells
17%
Prognostic Factors
17%
Transrectal Biopsy
17%
Cancer Database
15%
Germ Cell Tumor
15%
Predictive Value
13%
Germ Cell Neoplasia in Situ (GCNIS)
13%
Clinically Significant
12%
Cancer Registry
12%
Positive Surgical Margin
12%
Immunohistochemistry
11%
Re-biopsy
11%
Biochemical Failure
11%
AZGP1
11%
Randomized Controlled Trial
11%
Population Analysis
11%
ERG Protein Expression
11%
Cell Infiltration
11%
Natural Killer Cells
11%
Sentinel Lymph Node Biopsy
11%
Prostate Cancer Screening
11%
Smokers
11%
Smoking Cessation
11%
Pheochromocytoma
11%
Exercise Training
11%
Metastatic Urothelial Carcinoma
11%
Subnational Analysis
11%
Meta-analysis
11%
Bladder Biopsy
11%
Flexible Cystoscopy
11%
Population-based Study
11%
Testicle
10%
Cumulative Incidence
10%